Our aim with MIC News is to keep you up to date with current issues, including the safety, efficacy and availability of medicines.
Please feel free to e-mail us any questions, comments or suggestions.
The FDA has announced the withdrawal of andexanet alfa, due to concerns that the risks of the product outweigh the benefits based on the results of the ANNEXA-I trial. Andexanet
Scientists from Flinders University in Adelaide, Australia have reported that they have been able to isolate the cause of the rare adverse event known as VITT